A high‐throughput and simultaneous determination of combretastatin A‐4 phosphate and its metabolites in human plasma using HPLC–MS/MS: Application to a clinical pharmacokinetic study-Reference-Cited by-同舟云学术

A high‐throughput and simultaneous determination of combretastatin A‐4 phosphate and its metabolites in human plasma using HPLC–MS/MS: Application to a clinical pharmacokinetic study

Published:2021-07-06 Issue:11 Volume:35 Page:
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Wu Qizhen¹²^ORCID,Wang Qian³,Wang Yixuan¹,Huang Jingqiu¹,Fang Yalin¹,Wu Weiyi¹,Wu Wenying¹,Wu Fanhong⁴,Yu Xiaodong⁵,Sun Yan¹²

Affiliation:

1. Laboratory of Phase I Clinical Trials Fudan University Shanghai Cancer Center Shanghai China

2. Department of Oncology, Shanghai Medical College Fudan University Shanghai China

3. Clinical Research Center, Beijing Children's Hospital Capital Medical University, National Center for Children's Health Beijing China

4. Institute of Pharmaceutical Innovation, Shanghai Institute of Technology Shanghai Engineering Research Center of Green Fluoro Pharmaceutical Technology Shanghai China

5. Shanghai Ecust Biomedicine Company Limited Shanghai China

Funder

Major Projects of Special Development Funds in Zhangjiang National Independent Innovation Demonstration Zone, Shanghai

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bmc.5204

Reference25 articles.

1. Identification of the Human UDP-Glucuronosyltransferases Involved in the Glucuronidation of Combretastatin A-4

2. Efficacy of Selected Natural Products as Therapeutic Agents against Cancer

3. Combretastatin A-4 Analogs as Anticancer Agents

4. European Medicines Agency. (2011).Guideline on bioanalytical method validation.

5. Combretastatins: More Than Just Vascular Targeting Agents?

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-targeting drug delivery regimens based on vascular disrupting agents;Precision Medicine and Engineering;2024-09